Gladstone Institutional Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Gladstone Institutional Advisory's ELV Position: Q1 2026 in Review
Gladstone Institutional Advisory increased its Elevance Health (ELV) stake by 20% in Q1 2026, buying an estimated $48.3K and bringing the position to 893 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #720.
Gladstone Institutional Advisory first reported a position in ELV in Q1 2021 and has held it in 20 quarters since. The position peaked at $553K in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Gladstone Institutional Advisory held 893 shares of Elevance Health worth $262K as of Q1 2026.
- Gladstone Institutional Advisory bought 147 Elevance Health shares in Q1 2026, an estimated $48.3K.
- Elevance Health made up 0.01% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #720 holding.
- Gladstone Institutional Advisory first reported a position in Elevance Health in Q1 2021 and has held it in 20 quarters since.
- Gladstone Institutional Advisory's Elevance Health position peaked at $553K in Q4 2023.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.